Given the biological importance of CCND1, CDK2, and CDK6 in ER+ BC cell proliferation [33–35], we next focused on examining ER-associated enhancer regions of these three genes in the context of GR modulation by SGRMs [21, 36, 37]. This evidence concerns the gene CDK2 and breast cancer.